ESC Medical Systems raises $18 million in secondary offering:
This article was originally published in Clinica
ESC Medical Systems has raised $18 million net in a secondary public offering five months after going public. The electro-optic device developer sold 750,000 shares at $24.75 each at the same time as stockholders offered 3 million shares. ESC, based in Haifa, Israel, floated on the Nasdaq in January at a price of $15 a share (see Clinica No 687, p 9 and No 691, p 15).
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.